Literature DB >> 29266521

Exonic mutations and exon skipping: Lessons learned from DFNA5.

Kevin T Booth1,2, Hela Azaiez1, Kimia Kahrizi3, Donghong Wang1, Yuzhou Zhang1, Kathy Frees1, Carla Nishimura1, Hossein Najmabadi3, Richard J Smith1.   

Abstract

Dysregulation of splicing is a common factor underlying many inherited diseases including deafness. For one deafness-associated gene, DFNA5, perturbation of exon 8 splicing results in a constitutively active truncated protein. To date, only intronic mutations have been reported to cause exon 8 skipping in patients with DFNA5-related deafness. In five families with postlingual progressive autosomal dominant non-syndromic hearing loss, we employed two next-generation sequencing platforms-OtoSCOPE and whole exome sequencing-followed by variant filtering and prioritization based on both minor allele frequency and functional consequence using a customized bioinformatics pipeline to identify three novel and two recurrent mutations in DFNA5 that segregated with hearing loss in these families. The three novel mutations are all missense variants within exon 8 that are predicted computationally to decrease splicing efficiency or abolish it completely. We confirmed their functional impact in vitro using mini-genes carrying each mutant DFNA5 exon 8. In so doing, we present the first exonic mutations in DFNA5 to cause deafness, expand the mutational spectrum of DFNA5-related hearing loss, and highlight the importance of assessing the effect of coding variants on splicing.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  DFNA5; RNA-splicing; deafness; exon-skipping; non-syndromic hearing loss

Mesh:

Substances:

Year:  2018        PMID: 29266521      PMCID: PMC5805621          DOI: 10.1002/humu.23384

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  39 in total

1.  Clinical features of DFNA5.

Authors:  Els M R De Leenheer; Diederick A van Zuijlen; Lut Van Laer; Guy Van Camp; Patrick L M Huygen; Egbert H Huizing; Cor W R J Cremers
Journal:  Adv Otorhinolaryngol       Date:  2002

Review 2.  Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies.

Authors:  Ashish Dhir; Emanuele Buratti
Journal:  FEBS J       Date:  2010-01-15       Impact factor: 5.542

Review 3.  Spliceosome structure and function.

Authors:  Cindy L Will; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  Accurate and exact CNV identification from targeted high-throughput sequence data.

Authors:  Alex S Nord; Ming Lee; Mary-Claire King; Tom Walsh
Journal:  BMC Genomics       Date:  2011-04-12       Impact factor: 3.969

Review 5.  Autosomal dominant retinitis pigmentosa secondary to pre-mRNA splicing-factor gene PRPF31 (RP11): review of disease mechanism and report of a family with a novel 3-base pair insertion.

Authors:  Virginia M Utz; Craig D Beight; Meghan J Marino; Stephanie A Hagstrom; Elias I Traboulsi
Journal:  Ophthalmic Genet       Date:  2013-01-23       Impact factor: 1.803

6.  TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss.

Authors:  Hela Azaiez; Kevin T Booth; Fengxiao Bu; Patrick Huygen; Seiji B Shibata; A Eliot Shearer; Diana Kolbe; Nicole Meyer; E Ann Black-Ziegelbein; Richard J H Smith
Journal:  Hum Mutat       Date:  2014-05-06       Impact factor: 4.878

7.  PDZD7 and hearing loss: More than just a modifier.

Authors:  Kevin T Booth; Hela Azaiez; Kimia Kahrizi; Allen C Simpson; William T A Tollefson; Christina M Sloan; Nicole C Meyer; Mojgan Babanejad; Fariba Ardalani; Sanaz Arzhangi; Michael J Schnieders; Hossein Najmabadi; Richard J H Smith
Journal:  Am J Med Genet A       Date:  2015-09-29       Impact factor: 2.802

8.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5.

Authors:  L Van Laer; E H Huizing; M Verstreken; D van Zuijlen; J G Wauters; P J Bossuyt; P Van de Heyning; W T McGuirt; R J Smith; P J Willems; P K Legan; G P Richardson; G Van Camp
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

Review 9.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

Review 10.  Estimating the prevalence of functional exonic splice regulatory information.

Authors:  Rosina Savisaar; Laurence D Hurst
Journal:  Hum Genet       Date:  2017-04-12       Impact factor: 4.132

View more
  16 in total

1.  Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Authors:  Andrea M Oza; Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Jaclyn B Murry; Linda Hasadsri; Kiyomitsu Nara; Margaret Kenna; Kevin T Booth; Hela Azaiez; Andrew Griffith; Karen B Avraham; Hannie Kremer; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

2.  Old gene, new phenotype: splice-altering variants in CEACAM16 cause recessive non-syndromic hearing impairment.

Authors:  Kevin T Booth; Kimia Kahrizi; Hela Azaiez; Richard Jh Smith; Hossein Najmabadi
Journal:  J Med Genet       Date:  2018-04-27       Impact factor: 6.318

3.  Systematic quantification of the anion transport function of pendrin (SLC26A4) and its disease-associated variants.

Authors:  Koichiro Wasano; Satoe Takahashi; Samuel K Rosenberg; Takashi Kojima; Hideki Mutai; Tatsuo Matsunaga; Kaoru Ogawa; Kazuaki Homma
Journal:  Hum Mutat       Date:  2019-10-26       Impact factor: 4.878

4.  AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss.

Authors:  Ryan K Thorpe; W Daniel Walls; Rae Corrigan; Amanda Schaefer; Kai Wang; Patrick Huygen; Thomas L Casavant; Richard J H Smith
Journal:  Hum Genet       Date:  2022-01-17       Impact factor: 5.881

5.  When transcripts matter: delineating between non-syndromic hearing loss DFNB32 and hearing impairment infertile male syndrome (HIIMS).

Authors:  Marzieh Mohseni; Mojdeh Akbari; Kevin T Booth; Mojgan Babanejad; Hela Azaiez; Fariba Ardalani; Sanaz Arzhangi; Khadijeh Jalalvand; Nooshin Nikzat; Fatemeh Ghodratpour; Payman Jamali; Omid Ali Adeli; Haleh Habibi; Kimia Kahrizi; Hossein Najmabadi
Journal:  J Hum Genet       Date:  2020-03-30       Impact factor: 3.172

6.  Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation.

Authors:  Weiwei Xia; Yuanyuan Li; Mengying Wu; Qianqian Jin; Qian Wang; Shuzhen Li; Songming Huang; Aihua Zhang; Yue Zhang; Zhanjun Jia
Journal:  Cell Death Dis       Date:  2021-02-01       Impact factor: 8.469

7.  A biallelic variant in CLRN2 causes non-syndromic hearing loss in humans.

Authors:  Neda Mazaheri; Sheng-Jia Lin; Lucy A Dunbar; Barbara Vona; Reza Maroofian; Hela Azaiez; Kevin T Booth; Sandrine Vitry; Aboulfazl Rad; Franz Rüschendorf; Pratishtha Varshney; Ben Fowler; Christian Beetz; Kumar N Alagramam; David Murphy; Gholamreza Shariati; Alireza Sedaghat; Henry Houlden; Cassidy Petree; Shruthi VijayKumar; Richard J H Smith; Thomas Haaf; Aziz El-Amraoui; Michael R Bowl; Gaurav K Varshney; Hamid Galehdari
Journal:  Hum Genet       Date:  2021-01-26       Impact factor: 4.132

8.  DFNA5 (GSDME) c.991-15_991-13delTTC: Founder Mutation or Mutational Hotspot?

Authors:  Kevin T Booth; Hela Azaiez; Richard J H Smith
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

9.  Splice-altering variant in COL11A1 as a cause of nonsyndromic hearing loss DFNA37.

Authors:  Kevin T Booth; James W Askew; Zohreh Talebizadeh; Patrick L M Huygen; James Eudy; Judith Kenyon; Denise Hoover; Michael S Hildebrand; Katherine R Smith; Melanie Bahlo; William J Kimberling; Richard J H Smith; Hela Azaiez; Shelley D Smith
Journal:  Genet Med       Date:  2018-09-24       Impact factor: 8.822

10.  Deletion of exons 17 and 18 in prestin's STAS domain results in loss of function.

Authors:  Satoe Takahashi; Tetsuji Yamashita; Kazuaki Homma; Yingjie Zhou; Jian Zuo; Jing Zheng; Mary Ann Cheatham
Journal:  Sci Rep       Date:  2019-05-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.